Prosecution Insights
Last updated: July 17, 2026
Application No. 17/233,579

Toothpaste Compositions Comprising Silica And Surface Active Polymer

Non-Final OA §103
Filed
Apr 19, 2021
Priority
Apr 20, 2020 — provisional 63/012,419 +1 more
Examiner
ROBERTS, LEZAH
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
The Procter & Gamble Company
OA Round
7 (Non-Final)
49%
Grant Probability
Moderate
7-8
OA Rounds
0m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allowance Rate
373 granted / 764 resolved
-11.2% vs TC avg
Strong +36% interview lift
Without
With
+35.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
51 currently pending
Career history
838
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
77.9%
+37.9% vs TC avg
§102
3.9%
-36.1% vs TC avg
§112
2.1%
-37.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 764 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicants' arguments it the Request for Continued Examination, June 1, 2026, 2023, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims Claim Rejections - 35 USC § 103 – Obviousness (New Rejections) 1) Claims 1-3, 6, 8-15, 18-22, 25 and 27-34 and 38 are rejected under 35 U.S.C. 103 as being unpatentable over Yueh et al. (CN 1592605) in view of Pink et al. (WO 93/16680). Yueh et al. disclose oral care compositions having low water content. The compositions may comprise less than 10% water. The compositions are formulated into dentifrices which includes a toothpaste, paste or gel. Therefore the compositions are not required to be liquids. The compositions comprise a polyphosphate source wherein the average chain is greater than about 4. These include chains having a length of 6, 13 and 21. Wetting agents are used to prevent the toothpaste from drying. These include polyethylene glycol in an amount ranging from 0.1% to 70% (page 2, paragraph 1). An ion active is added and is chosen from fluoride ions, stannous ions, zinc ions and mixtures thereof. Fluoride ions include sodium fluoride, stannous fluoride and sodium monofluoro-phosphoric acid. Stannous metal ions include stannous fluoride and stannous chloride. Zinc ions include zinc oxide, zinc sulfate, zinc chloride, zinc citrate and zinc lactate (page 7). Dental abrasives include precipitated silica or silica gel and comprises about 6% to 70% of the composition. The silica has a grain diameter of preferably 5 microns to about 15 microns. Abrasives also include calcium abrasives. These include calcium carbonate, tricalcium phosphate and calcium pyrophosphate. Peroxide sources may be added to the compositions and include hydrogen peroxide and carbamide peroxide, meeting whitening agents. Zinc is optional. When stannous is present, polyvinyl pyrrolidone may be added to hydrate the composition. This comprises about 1% to about 5% of the composition (page 11, paragraph 2). The compositions include thickening agents selected from the group consisting of polysaccharides, carbomers, poloxamers, modified celluloses, and mixtures thereof (Abstract). An example comprises stannous fluoride, stannous chloride, 20% sodium polyphosphate (Glass H), carrageenan, polyethylene glycol, 12.5% Zeodent 119 (silica), 12.5% Zeodent 109 (silica) and 1.5% Plasdone S-639 (polyvinyl pyrrolidone). No water or zinc is added (Example 16). Yueh et al. differ from the instant claims insofar as they do not disclose specifically that the PVP is a homopolymer although they do disclose a polymer comprising PVP. Pink discloses that polyvinyl pyrrolidone is used as a bacterial anti-adherence agent. Generally, it is prima facie obvious to select a known material for incorporation into a composition, based on its recognized suitability for its intended use. See MPEP 2144.07. It would have been obvious to one of ordinary skill in the art prior to filing the instant application to have used a homopolymer of PVP as the PVP or have added it to the PVP copolymer of Yue et al. motivated by the desire to obtain its bacterial anti-adherence properties. The combination would meet the limitations of claims 6 and 25. Further, it would have been obvious to one of ordinary skill in the prior to filing the instant application to have added a whitening agent, an additional abrasive and/or a surface active polymer to obtain their therapeutic property and because the addition of the components are suggested by Yueh et al. In regards to ratio of surface active polymer to silica surface area of from about 0.01 to about 2.0 mg/m2 and 0.05 to about 0.8 mg/m2; and a viscosity increase of at least about 300% based on the Creep Test, the composition of Yueh et al. in view of Pink et al. comprises PVP in an amount of 1.5% and silica from 25%, which is encompassed by the amounts recited by the instant claims. Therefore the toothpaste composition of Yue et al. in view of Pink et al. would have substantially the same ratio of surface active polymer to silica surface and the viscosity increase as the composition of the instant claims. 2) Claims 1-3, 6, 8-15, 18-22, 25 and 27-34 and 38 are rejected under 35 U.S.C. 103 as being unpatentable over 杉山 眞次 (JP 4803889, JP889) in view of Yueh et al. (CN 1592605). JP889 discloses a non-aqueous toothpaste comprising polyvinyl pyrrolidone. The polyvinylpyrrolidone has a number average molecular weight of 10,000 to 360,000 and comprises 1 to 10% by mass of the composition. Silica comprises 0.5 to 30% by weight of the composition. An example comprises 1% PVP, 5% silica, 0.2 sodium fluoride and no added water (Example 8). The compositions do not require zinc. JP889 differs from the instant claims insofar as it does not disclose the particle size of silica. Yueh et al. disclose oral care compositions having low water content. The compositions comprise a polyphosphate source wherein the average chain is greater than about 4. These include chains having a length of 6, 13 and 21. An ion active is added and is chosen from fluoride ions, stannous ions, zinc ions and mixtures thereof. Fluoride ions include sodium fluoride, stannous fluoride and sodium monofluoro-phosphoric acid. Stannous metal ions include stannous fluoride and stannous chloride. Zinc ions include zinc oxide, zinc sulfate, zinc chloride, zinc citrate and zinc lactate (page 7). Dental abrasives include precipitated silica or silica gel and comprises about 6% to 70% of the composition. The silica has a grain diameter of preferably 5 microns to about 15 microns. Abrasives also include calcium abrasives. These include calcium carbonate, tricalcium phosphate and calcium pyrophosphate. Peroxide sources may be added to the compositions and include hydrogen peroxide and carbamide peroxide, meeting whitening agents. Zinc is optional. When stannous is present, polyvinyl pyrrolidone may be added to hydrate the composition. Generally, it is prima facie obvious to select a known material for incorporation into a composition, based on its recognized suitability for its intended use. See MPEP 2144.07. It would have been obvious to one of ordinary skill in the art prior to filing the instant application to have used the silica of Yueh et al. having a specific particle size in the composition of JP889 because they are suitable silica for oral care compositions. It would have been obvious to one of ordinary skill in the art prior to filing the instant application to have added a pyrophosphate, an additional polymer comprising vinylpyrrolidone such as Plasdone and/or a poloxamer, hydrogen peroxide, a stannous fluoride and a zinc citrate motivated by the desire to obtain their known therapeutic effect as an anticalculus agent, a thickener, a whitening agent, an anticaries agent and an antimicrobial, respectively. In regards to ratio of surface active polymer to silica surface area of from about 0.01 to about 2.0 mg/m2 and 0.05 to about 0.8 mg/m2; and a viscosity increase of at least about 300% based on the Creep Test, the composition of JP889 in view of Yueh et al. comprises PVP in an amount of 1.5% and silica from 25%, which is encompassed by the amounts recited by the instant claims. Therefore the toothpaste composition of Yue et al. in view of Pink et al. would have substantially the same ratio of surface active polymer to silica surface and the viscosity increase as the composition of the instant claims. Conclusion Claims 1-3, 6, 8-15, 18-22, 25 and 27-34 and 38 are rejected. No claims allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LEZAH ROBERTS whose telephone number is (571)272-1071. The examiner can normally be reached Monday-Friday 11:00-7:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana Kaup can be reached on 571-272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LEZAH ROBERTS/ Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Show 18 earlier events
Jun 04, 2025
Response after Non-Final Action
Jun 06, 2025
Response after Non-Final Action
Jul 07, 2025
Response after Non-Final Action
Jan 06, 2026
Response after Non-Final Action
Mar 25, 2026
Response after Non-Final Action
Jun 01, 2026
Request for Continued Examination
Jun 04, 2026
Response after Non-Final Action
Jun 29, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12661309
PREPARATION AND EFFICACY OF TOOTH WHITENING TABLET INCLUDING SHMP
5y 0m to grant Granted Jun 23, 2026
Patent 12594229
Personal Care Compositions and Methods for the Same
5y 2m to grant Granted Apr 07, 2026
Patent 12594241
TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF
2y 7m to grant Granted Apr 07, 2026
Patent 12582583
ORAL CARE PRODUCT COMPRISING AN ORAL CARE RHEOLOGICAL SOLID COMPOSITION
4y 11m to grant Granted Mar 24, 2026
Patent 12558387
MULTI-VIRUS ANTI-INFECTIVITY AND PRO-IMMUNITY ASSEMBLY
2y 2m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
49%
Grant Probability
85%
With Interview (+35.8%)
4y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 764 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month